ConductScience.org, home

Paper33567282

Dynamic adoption of anergy by antigen-exhausted CD4+ T cells.

Trefzer A and 12 others. Cell Rep, 2021. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Dynamic adoption of anergy by antigen-exhausted CD4+ T cells. Papers, record 33567282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33567282

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dynamic adoption of anergy by antigen-exhausted CD4+ T cells.
PubMed
Journal
Cell Rep
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
1.76
iCite
Revised in PubMed
2022-01-17
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Trefzer AAnne
2Kadam PPallavi
3Wang SHShu-Hung
4Pennavaria SStefanie
5Lober BBenedikt
6Akçabozan BBatuhan
7Kranich JJan
8Brocker TThomas
9Nakano NNaoko
10Irmler MMartin
11Beckers JJohannes
12Straub TTobias
13Obst RReinhard

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntigensMajor topic
Calcium SignalingMajor topic
Clonal AnergyMajor topic
Gene Expression RegulationMajor topic
MAP Kinase Signaling SystemMajor topic
Th1 CellsMajor topic
Animals
B-Lymphocytes
Female
Gene Expression Profiling
Mechanistic Target of Rapamycin Complex 1
Mice
Mice, Transgenic
Receptors, Antigen, T-Cell

Source PubMed

Download CSV of topics

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
42960354From Dysfunction to Differentiation: A New Paradigm of T Cell Exhaustion.Acta Naturae2026https://conductscience.org/library/papers/42960354PubMed
41910264Non-suppressible HIV viremia sustained by clonally expanded CD4+ T cells harboring a genomically defective provirus with an immune-evasive protein expression profile.mBio2026https://conductscience.org/library/papers/41910264PubMed
41799779A prognostic 19-gene signature and LBP-mediated immune dysregulation define the tumor microenvironment in poor-prognosis KIRC.Int J Med Sci2026https://conductscience.org/library/papers/41799779PubMed
41751962Do Metastatic Cells Arise from PD-L1+ Cell Niches in Gastric Adenocarcinoma?Int J Mol Sci2026https://conductscience.org/library/papers/41751962PubMed
41531737CCL20-CCR6 signaling alters the metabolic reprogramming to promote the pathogenic Th17 cell differentiation.iScience2026https://conductscience.org/library/papers/41531737PubMed
41196654Flt3L-Derived Antigen-Presenting Cell Transfer in Neonatal NOD Mice Reduces the Incidence of Type 1 Diabetes.Diabetes2026https://conductscience.org/library/papers/41196654PubMed
41034589Efferocytic remodelling of pancreatic islet macrophages by limited β-cell death.Nature2025https://conductscience.org/library/papers/41034589PubMed
41034190Multiple sclerosis: molecular pathogenesis and therapeutic intervention.Signal Transduct Target Ther2025https://conductscience.org/library/papers/41034190PubMed
40726062Aging and Viral Evolution Impair Immunity Against Dominant Pan-Coronavirus-Reactive T Cell Epitope.Eur J Immunol2025https://conductscience.org/library/papers/40726062PubMed
40707326Cell-intrinsic CD4 T cell tolerance: a new frontier in therapy?Trends Immunol2025https://conductscience.org/library/papers/40707326PubMed
40672265Resolving ScRNA-Seq Signatures of Antigen-Specific CD4+ T Cells in Tolerance across Semi-Allogeneic Transplantation and Pregnancy.bioRxiv2025https://conductscience.org/library/papers/40672265PubMed
40450686Ocular immune privilege in action: The living eye imposes unique regulatory and anergic gene signatures on uveitogenic T cells.Cell Rep2025https://conductscience.org/library/papers/40450686PubMed
40236693Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies.Front Immunol2025https://conductscience.org/library/papers/40236693PubMed
40165970Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease models.Front Immunol2025https://conductscience.org/library/papers/40165970PubMed
40133260Kinetically activating nanovaccine mimicking multidimensional immunomodulation of natural infection for broad protection against heterologous viruses in animal models.Nat Commun2025https://conductscience.org/library/papers/40133260PubMed
39589811Endogenous antigens shape the transcriptome and TCR repertoire in an autoimmune arthritis model.J Clin Invest2024https://conductscience.org/library/papers/39589811PubMed
39214091CD4+ T cells reactive to a hybrid peptide from insulin-chromogranin A adopt a distinct effector fate and are pathogenic in autoimmune diabetes.Immunity2024https://conductscience.org/library/papers/39214091PubMed
38319998Cbl-b mitigates the responsiveness of naive CD8+ T cells that experience extensive tonic T cell receptor signaling.Sci Signal2024https://conductscience.org/library/papers/38319998PubMed
38086932Therapeutic induction of antigen-specific immune tolerance.Nat Rev Immunol2024https://conductscience.org/library/papers/38086932PubMed
37862030BATF represses BIM to sustain tolerant T cells in the periphery.J Exp Med2023https://conductscience.org/library/papers/37862030PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33567282

GET https://conductscience.org/api/papers/v1/33567282/cited_by?page=2